InsidersTradesSigma
Henry Schein INC Stock: price and management transactions · United States · SEC (Form 4)
Follow the Henry Schein INC share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, Henry Schein INC has logged 241 reports. Market capitalisation: €9.9bn. The latest transaction was filed on 15 June 2026 (Attribution). Among the most active insiders: BERGMAN STANLEY M. All data is openly available.
241
Insider Decl.
0
Thresholds
€77,592
1 ops.
Buy Volume
€32m
66 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Henry Schein INC Buy (bullish), based on 15 analysts. Average price target: US$88.73.
35Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 14,076 of 25,724 companies
49.2
score / 100
Value55
Quality43
FCF yld5.3%
Earn yld4.0%
EV/EBITDA13.8x
ROE8.8%
Gross mgn31%
Net mgn3.0%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 15 June 2026
Declarations241 total
2,215 sharesCommon Stock, par value $0.01 per shareSEC:0001190297-26-000004:0
50 shares0Common Stock, par value $0.01 per shareSEC:0001193125-26-237318:0
1,040 shares0Common Stock, par value $0.01 per shareSEC:0001193125-26-234868:0
60,631 shares0Common Stock, par value $0.01 per shareSEC:0002025230-26-000004:0
75 shares0Common Stock par value $0.01 per shreSEC:0000950170-25-084307:0
625 shares@ US$72.0825.0% of flowCommon Stock, par value $0.01 per shareSEC:0000950170-25-076933:0
630 shares0Common Stock par value $0.01 per shreSEC:0000950170-25-074331:0
1,140 shares0Common Stock par value $0.01 per shreSEC:0000950170-25-069340:0
2,604 shares@ US$71.04414.4% of flowCommon Stock, par value $0.01 per shareSEC:0000950170-25-042706:0
4,036 shares@ US$71.1514.1% of flowCommon Stock, par value $0.01 per shareSEC:0000950170-25-042684:0
350 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-042697:0
27,617 shares0Common Stock par value $0.01 per shreSEC:0000950170-25-040319:0
5,390 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-040371:0
535 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-040391:0
6,433 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-040380:0
6,954 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-040415:0
3,477 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-040360:0
6,315 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-040328:0
2,087 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-040311:0
3,998 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-040404:0
950 shares0Common Stock par value $0.01 per shreSEC:0000950170-25-039570:0
340 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-039572:0
710 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-037383:0
3,313 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-037374:0
26,507 shares0Common Stock, par value $0.01 per shareSEC:0000950170-25-037378:0
25 of 241 declarations
About Henry Schein INC
Henry Schein Inc. is a leading provider of healthcare solutions for office-based dental and medical practitioners. The company is listed on the U.S. market, NASDAQ (United States), was founded in 1932, and is headquartered in Melville, New York. What began as a dental-focused distributor has evolved into a broader healthcare platform spanning consumables, equipment, specialty products, software, and value-added services for clinicians and practice owners. The business is now organized around three core segments. First, Global Distribution and Value-Added Services covers the sale of branded and private-label merchandise, equipment, technical services, and advisory offerings such as practice transition, consulting, continuing education, and financial services. Second, Global Specialty Products includes manufacturing, marketing, and sales of dental implant and biomaterial products, as well as endodontic, orthodontic, orthopedic, and other healthcare-related products. Third, Global Technology comprises practice management software, e-services, and related digital solutions. This mix of distribution, proprietary products, and software creates a diversified model with recurring demand characteristics and a broad customer base. From a competitive standpoint, Henry Schein holds a strong position in the dental and medical office supply chain, supported by its scale, logistics footprint, technical service capabilities, and integrated offering. The company operates in 33 countries and territories, giving it meaningful international reach beyond its U.S. home market. Its competitive advantages are particularly visible in relationships with independent practitioners, where product availability, service quality, software integration, and equipment support matter as much as price. At the same time, the company faces intense competition from specialty distributors, manufacturers, and online commerce platforms. Recent developments are important for investors. In January 2025, Henry Schein announced a strategic investment by KKR, board changes, and a value-creation collaboration framework. The company also updated its reportable segment structure in 2025 to better align external reporting with management’s internal view of the business. Operationally, 2025 results highlighted growth in medical distribution, specialty products, and technology, supported by underlying demand from dental and physician offices, acquisitions, and expanding cloud-based software offerings such as Dentrix Ascend and Dentally. For international equity investors, HSIC represents a mature U.S. healthcare franchise with global exposure, a resilient end-market, and an evolving mix of distribution, specialty manufacturing, and digital workflow solutions.
